In focus · trending topic

contract manufacturing

33 stories · following the connections

Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent Developments

By Nasdaq OMXJul 14, 2017, 8:13 PM UTC